Alzheimer's Disease

Metallomic Signature#

The Metal-Disease Matrix: A Cross-Source Synthesis identifies AD's profile as: copper (Cu) ↓ (brain), zinc (Zn) ↑↓ (plaques ↑, serum ↓), iron (Fe) ↑ (brain accumulation), selenium (Se) ↓, manganese (Mn) ↑↓, lead (Pb) ↑ (epigenetic), cadmium (Cd) ↑, mercury (Hg) ↑, As ↑, aluminum (Al) ↑ (brain).

The Copper Paradox: Brain Depletion, Peripheral Excess#

This is the defining metallomic feature of Alzheimer's disease. Post-mortem brain metallomics reveals widespread copper (Cu) decreases across multiple brain regions in AD (also in DLB and PDD), with copper changes contributing most to the multivariate separation between dementia types.^{[3]Scholefield et al. 2024 — Brain Metallomic Signatures Distinguish DLB from AD and PDDMelissa Scholefield, Stephanie J. Church, Jingshu Xu et al. · 2024Open reference 3 ↓}

copper depletion spans hippocampus, cingulate gyrus, middle temporal gyrus, substantia nigra, primary visual cortex, and putamen.^{[3]Scholefield et al. 2024 — Brain Metallomic Signatures Distinguish DLB from AD and PDDMelissa Scholefield, Stephanie J. Church, Jingshu Xu et al. · 2024Open reference 3 ↓} Yet peripherally, copper is often normal or elevated—the paradox suggests disturbed copper trafficking rather than simple depletion.

Ceruloplasmin dysfunction is a candidate mechanism: it both elevates circulating copper and fails to deliver copper to the brain.^{[4]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 4 ↓}

copper-amyloid-beta interactions promote toxic oligomer formation—copper binds A-beta at Histidine residues, catalyzing ROS production and accelerating aggregation.^{[4]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 4 ↓}

copper depletion impairs cytochrome c oxidase (mitochondrial respiration), copper/zinc superoxide dismutase (Cu/Zn-SOD) (antioxidant defense), and ceruloplasmin (iron homeostasis) in brain tissue.

Iron: Accumulation and Ferroptosis#

Iron accumulates in hippocampus and cortex in AD.^{[4]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 4 ↓} Iron-catalyzed Fenton reactions generate hydroxyl radicals driving lipid peroxidation. Ferroptosis (iron-dependent lipid peroxidation cell death) is an emerging cell death pathway in AD, parallel to its established role in Parkinson's Disease.

Transferrin receptor and ferritin alterations documented in AD brain.^{[4]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 4 ↓} Iron chelation (deferiprone) is under investigation as a therapeutic strategy.

Lead: Strongest Epidemiological Evidence#

lead (Pb) is the most extensively studied metal in relation to AD; cumulative bone lead levels provide better exposure estimates than blood lead.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓}

Higher tibia lead associated with cognitive decline in older adults.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓}

Early-life lead exposure produces latent effects on AD-related gene expression through epigenetic mechanisms that manifest decades later—the "developmental origins" hypothesis.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓}

lead disrupts calcium signaling (mimics calcium(II) (Ca2+) in signaling pathways), promotes Oxidative Stress, and affects protein phosphorylation.^{[4]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 4 ↓} lead induces BBB disruption, enabling further metal and toxin entry to the brain.^{[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓}

21 of 46 mechanistic studies reviewed focused on lead—the most of any metal.^{[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓}

Zinc: Enriched in Plaques, Depleted Systemically#

Zinc accumulates in amyloid plaques, where it induces A-beta aggregation;^{[4]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 4 ↓} 100 uM zinc(II) (Zn2+) produced 5-14 fold increases in A-beta aggregation rates in vitro.^{[7]Benoit & Maier 2021 — Nickel Chelator Inhibits Amyloid-Beta AggregationBenoit, S.L., Bhatt et al. · 2021Open reference 7 ↓}

Serum/plasma zinc is reduced in AD patients. Zinc transporter dysfunction documented in AD brains.

The dual role of zinc—protective at physiological levels (antioxidant, synaptic function) but pathological when trapped in plaques—mirrors the copper (Cu) paradox.

Nickel: Newly Recognized A-beta Aggregation Driver#

nickel(II) (Ni2+) enhances A-beta-40 aggregation 5.7-fold at 100 uM.^{[7]Benoit & Maier 2021 — Nickel Chelator Inhibits Amyloid-Beta AggregationBenoit, S.L., Bhatt et al. · 2021Open reference 7 ↓} Commercial recombinant A-beta-40 preparations contain 1,005 ug nickel per gram of peptide, reflecting intrinsic nickel binding.^{[7]Benoit & Maier 2021 — Nickel Chelator Inhibits Amyloid-Beta AggregationBenoit, S.L., Bhatt et al. · 2021Open reference 7 ↓}

The nickel chelator dimethylglyoxime (DMG) inhibits A-beta-40 aggregation 40-85% in a dose-dependent manner.^{[8]The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregationBenoit SL, Bhatt RJ, Maier RJ · 2021Open reference 8 ↓}

nickel chelation represents a dual therapeutic strategy against both the "metal hypothesis" and the "infection hypothesis" of AD by disabling nickel-dependent pathogen enzymes (Hydrogenase, Urease).^{[8]The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregationBenoit SL, Bhatt RJ, Maier RJ · 2021Open reference 8 ↓}

Aluminum: Controversial but Persistent#

aluminum (Al) accumulates in brain tissue in AD Metal-Disease Matrix: A Cross-Source Synthesis. Continues to be debated as a risk factor; some studies show increased aluminum in AD brain regions.^{[9]The Health Effects of Aluminum ExposureKatrin Klotz, Wobbeke Weistenhofer, Frauke Neff et al. · 2017Open reference 9 ↓} aluminum's neurotoxicity mechanisms include oxidative stress, inflammatory cytokine induction, and interference with iron homeostasis.

Other Toxic Metals#

Arsenic: Increases A-beta(1-42) production and BACE1 activity; RAGE levels up 220-fold in animal models; dose-dependent tau phosphorylation via GSK3-beta and ERK1/2.^{[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓}

Cadmium: BBB disruption, calcium signaling disruption, mitochondrial dysfunction; blood cadmium (Cd) associated with lower cognitive scores.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓}

Mercury: Both inorganic and methylmercury are neurotoxic; can increase A-beta production and tau phosphorylation; fish consumption confounds epidemiology (source of methylmercury (MeHg) but also neuroprotective omega-3).^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓}

Manganese: Impairs autophagy; Drp1 inhibition protective against manganese (Mn)-induced autophagic impairment; acute manganese exposure increases seizure susceptibility in AD mouse models.^{[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓}

Selenium Depletion#

selenium (Se) deficiency associated with increased neurodegeneration risk via impaired selenoproteins (glutathione peroxidases, thioredoxin reductases).^{[4]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 4 ↓} selenium supplementation may have neuroprotective effects, though evidence is preliminary.

Shared Mechanistic Pathways#

All metals converge on a small set of overlapping AD-relevant pathways.^{[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓}

Oxidative stress and mitochondrial dysfunction—universal across all metals. Amyloid-beta aggregation—copper (Cu) and zinc (Zn) bind A-beta directly; arsenic (As) increases BACE1-mediated production. Tau hyperphosphorylation—As activates GSK3-beta and ERK1/2; lead (Pb) affects protein phosphorylation.^{[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓}

BBB disruption—lead and cadmium (Cd) specifically damage the blood-brain barrier.^{[6]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 6 ↓} Neuroinflammation—microglial activation by metals; LPS from gut bacteria amplifies via NF-kB.^{[10]Microglia in neurodegenerative diseases: mechanism and potential therapeutic targetsGao C, Jiang J, Tan Y et al. · 2023Open reference 10 ↓}

Epigenetic modification—lead produces latent epigenetic effects decades after exposure; arsenic depletes SAM (universal methyl donor).^{[11]Contributions of heavy metal exposure to late-onset Alzheimer's diseaseBakulski KM, et al. · 2025Open reference 11 ↓}

Gut Microbiome Connection#

The gut-brain axis is a major emerging pathway in AD metallomic research. AD patients show reduced Bacteroidetes diversity, decreased Firmicutes, and increased Gram-negative bacteria.^{[12]Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and NeurodegenerationGentile F, Doneddu PE, Riva N et al. · 2020Open reference 12 ↓} Increased H. pylori, Escherichia/Shigella, K. pneumoniae, B. fragilis; decreased Eubacterium rectale and Bacteroides in AD.^{[13]Effects of gut microbiota on neurodegenerative diseasesKhatoon S, Kalam N, Rashid S et al. · 2023Open reference 13 ↓}

LPS enhances amyloid-beta fibrillization and triggers NF-kB signaling.^{[12]Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and NeurodegenerationGentile F, Doneddu PE, Riva N et al. · 2020Open reference 12 ↓}

Bacterial amyloids (curli from Escherichia coli) can cross-seed with cerebral amyloid-beta, providing a direct microbial-to-neurodegeneration pathway.^{[12]Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and NeurodegenerationGentile F, Doneddu PE, Riva N et al. · 2020Open reference 12 ↓[14]Gut microbial imbalance and neurodegenerative proteinopathies: from molecular mechanisms to prospects of clinical applicationsAlonso-Garcia P, Martin R, Martinez-Pinilla E · 2021Open reference 14 ↓}

TMAO (trimethylamine N-oxide) from gut bacteria traverses the BBB and is found at increased levels in CSF of cognitively impaired AD patients.^{[13]Effects of gut microbiota on neurodegenerative diseasesKhatoon S, Kalam N, Rashid S et al. · 2023Open reference 13 ↓}

FMT from wild-type to AD mice alleviated cognitive impairment and reduced A-beta plaque burden.^{[12]Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and NeurodegenerationGentile F, Doneddu PE, Riva N et al. · 2020Open reference 12 ↓} SCFAs are reduced in AD; sodium Butyrate curbs cholesterol-induced neuronal amyloidosis.^{[12]Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and NeurodegenerationGentile F, Doneddu PE, Riva N et al. · 2020Open reference 12 ↓}

The metal-microbiome connection: Heavy Metals (lead (Pb), cadmium (Cd), mercury (Hg), arsenic (As)) disrupt gut barrier integrity,^{[15]Effects of Heavy Metals on Gut Barrier Integrity and Gut MicrobiotaSweta Ghosh, Syam P. Nukavarpu, Venkatakrishna Rao Jala · 2024Open reference 15 ↓} reshaping the microbiome toward metal-tolerant, LPS-producing Gram-negative species. This gut-derived Metal-Driven Inflammation reaches the brain via the vagus nerve and systemic circulation, amplifying metal-induced neuroinflammation.

Environmental Metal Exposure Links#

Occupational exposure (welding, mining, battery manufacturing) provides high-dose lead (Pb) and manganese (Mn) exposure.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓} Drinking water contamination: arsenic (As) in water linked to cognitive deficits in some populations.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓}

Air pollution: particulate matter carries metals (lead, manganese, nickel (Ni)) to the brain via olfactory pathway.^{[16]Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseasesChin-Chan M, Navarro-Yepes J, Quintanilla-Vega B · 2015Open reference 16 ↓} Dietary metals: fish (methylmercury (MeHg) but also omega-3), contaminated rice (arsenic, cadmium (Cd)), processed foods.^{[17]Heavy metals in the diet: unraveling the molecular pathways linked to neurodegenerative disease riskGuevara-Ramirez P, Tamayo-Trujillo R, Cadena-Ullauri S et al. · 2024Open reference 17 ↓}

Cigarette smoking: major non-dietary cadmium source.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓}

Developmental Vulnerability#

AD may have its origins decades before symptom onset.

Early-life lead (Pb) exposure alters epigenetic programming of AD-related genes, manifesting as disease 40-60 years later.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓} Obesity and T2D at midlife increase AD risk by up to 74%; metals contribute to both conditions.^{[12]Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and NeurodegenerationGentile F, Doneddu PE, Riva N et al. · 2020Open reference 12 ↓}

The APOE4 genotype may modify metal-AD associations, creating gene-environment interactions.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓} Mixed metal exposures during development remain critically understudied.^{[5]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 5 ↓}